| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD001938 |
| P698 | PubMed publication ID | 11279741 |
| P2093 | author name string | M R Miller | |
| N R Powe | |||
| K A Robinson | |||
| E B Bass | |||
| S N Goodman | |||
| J B Segal | |||
| R L McNamara | |||
| P2860 | cites work | Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin | Q33671179 |
| Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis | Q33744558 | ||
| Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators | Q33863941 | ||
| Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team | Q40675424 | ||
| Incidence of and risk factors for atrial fibrillation in older adults. | Q50625635 | ||
| Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat | Q50658605 | ||
| Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. | Q53360138 | ||
| Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation | Q62023675 | ||
| Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals | Q71976184 | ||
| Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography | Q74429767 | ||
| P433 | issue | 1 | |
| P921 | main subject | anticoagulant | Q215118 |
| atrial fibrillation | Q815819 | ||
| anticoagulation | Q63279445 | ||
| P304 | page(s) | CD001938 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. |
| Q24246637 | Antiplatelet agents and anticoagulants for hypertension |
| Q28194656 | Antithrombotic drugs in the prevention of ischemic stroke |
| Q24795377 | Atrial fibrillation in a primary care practice: prevalence and management |
| Q34561536 | Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation |
| Q24200617 | Direct thrombin inhibitors and factor Xa inhibitors for atrial fibrillation |
| Q94337721 | Direct thrombin inhibitors and factor Xa inhibitors for atrial fibrillation |
| Q28187842 | Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation |
| Q36801083 | Poor adherence to anticoagulation guidelines in patients with non-valvular atrial fibrillation treated in a tertiary cardiology unit |
| Q36348641 | Thyrotoxic atrial fibrillation |
| Q47559889 | Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry |
| Q43058319 | When should I stop anticoagulation for atrial fibrillation? |
| Q80923321 | [Anticoagulants for patients with chronic auricular fibrillation: when are they indicated?] |
| Q79780889 | [When the risk exceeds the benefit] |
Search more.